Company page

Neuroscientific Biopharmaceuticals Ltd.

Neuroscientific Biopharmaceuticals Ltd. (ticker: NSB) is a public company listed on the Australian market, with a market capitalization of approximately AUD 17.72 million. The company focuses on developing innovative biopharmaceutical products aimed at addressing neurological disorders. Its commitment to research and development positions it within the growing biopharmaceutical sector.

NSB:ASXUpdated August 21, 2026
Neuroscientific Biopharmaceuticals Ltd. logo
Ticker
NSB:ASX
Asset type
Stock
Market cap
$18.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD